{"name":"Aprea Therapeutics","slug":"aprea-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":23895875,"netIncome":-12599569,"cash":15933401,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBGTDRzTjNxRzJRY3F0ZW1hXzNQRGJ5UW9ibzh1SENTczlrZlJ0dmtBajhNYzJJSWxGSGFHYnhvbkh5cG9PeFpNMVFzN3lLMWtEZ1dRajJVb1VLbzR1Q1JyR0NYWVdmbVc5S1lEMUs2RlVOMklBOS1F?oc=5","date":"2026-04-05","type":"pipeline","source":"BUCKSCO.Today","summary":"Two Life Sciences Companies with Doylestown Connections Raise $119M - BUCKSCO.Today","headline":"Two Life Sciences Companies with Doylestown Connections Raise $119M","sentiment":"neutral"},{"date":"2026-04-01","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2026-03-16","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQS2VKS21XU2tnTkRPRFNiQ3R0aE1kR1U4RllzZE5uOVFwWW1yY2xEaHB6UUkzMUdGQmlQRVk4dVlWeTN0ZnFnak5hd2hPc3liTUNhak5XTWFqN1NNUjFwTm1FYU9OS3Z3TGFyQzV1bTFqZGVOUlhyU2QyM3VaNkhhRmN1T2ZiNjNXNWNPZmdvNzZhTFE3M1hpUi1MWlMtMVJ6NGdZNUJralFqOFg4d1hlanBpTTM?oc=5","date":"2026-02-20","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga","headline":"12 Health Care Stocks Moving In Friday's Pre-Market Session","sentiment":"neutral"},{"date":"2026-02-18","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBscVlhT2h4SlJvZTB4dDFZa1lRYjdYQW1ZWVhUb3BDS1lzZHRVNmY1ZFJ5aEZGcFVqZEgwYmlDbnd0SWhyLXN0bzlCOUhJOUpPcGJjTDlMaGhFRkltdFJHTmo2aGtFX2VtRVRjSGgyRQ?oc=5","date":"2026-02-17","type":"pipeline","source":"VISTA.Today","summary":"Doylestown’s Aprea Therapeutics Names Industry Veteran as Chief Medical Advisor - VISTA.Today","headline":"Doylestown’s Aprea Therapeutics Names Industry Veteran as Chief Medical Advisor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxQbGxKU1dCUHlNcnVRak1mOVJTdktfSURRbHZCWGJ6akkwbENNVW9ESGdBUDVQQ2JNNTZuMFB6RDFCajJCS1ZMTEoxNHI4OFNGQmkteWdyT04yNEwyMEtkM3RPNnJwUlhLeVVLbHNUc3NsUk1uMlh4a1VrdXJGZVVXNFBNd3pIdFllZXpMMXI1NkZxODJIcmFVMjJLOTQ1RnJLS1pYRmx1d1RRT3FTdEdHeFNXQ01HSWdYVEV6T0ZnZVVwUElNdzFuY1Q4Tk5fZDhWRjE3dFJlcEQyN2F2Z3FvalJyVDBSQkMxcGRhTzRzWEg?oc=5","date":"2026-02-04","type":"pipeline","source":"GlobeNewswire","summary":"Aprea Therapeutics Appoints Industry Veteran Eugene Kennedy, MD, as Chief Medical Advisor - GlobeNewswire","headline":"Aprea Therapeutics Appoints Industry Veteran Eugene Kennedy, MD, as Chief Medical Advisor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxONlYxTy1LYXhfWVB1S3RBVU5pVVdwNUptbnBkSHppb211WG1DWkIwVVByMmtDTlN1X3lhSDJ6RDlQaVRWYXg4eTV6VTduZ1EtWlJqaTd1VnV0dzg4LUZWcnU1Sm9aYVVPTjJ2MEdIUnNGNzFUMHJfaFVQU1IxY3Fpc1VUclNxNVF4Wm53QjktM19GRlJWOHRyZThWX2stNFpIUFBzZUdxdnZMZw?oc=5","date":"2026-01-29","type":"trial","source":"StockInvest.us","summary":"Aprea Therapeutics Shares Slide After Phase 1 Cancer Drug Results Disappoint - StockInvest.us","headline":"Aprea Therapeutics Shares Slide After Phase 1 Cancer Drug Results Disappoint","sentiment":"negative"},{"date":"2026-01-29","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-03","type":"pipeline","source":"simplywall.st","summary":"Aprea Therapeutics, Inc. (NASDAQ:APRE): Is Breakeven Near? - simplywall.st","headline":"Aprea Therapeutics, Inc. (NASDAQ:APRE): Is Breakeven Near?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPdEtjcTBVb1RXQVlaRGRVbDJkTC1UTVY2Ung1dlFLajU3UXFTeWlqUUwwWVlhWkZZUGJqam1sMnU4M0pWWWoza0RFbjk2aHJKVFpvZTcxeVhvd3dkWkNhTk1yaTRFVUowYXJJR2JnMV9DZ2stT19kRWlTUlFXR2hyQ1l3enBhVzZHbzVJNnpzSTlxQQ?oc=5","date":"2025-08-07","type":"deal","source":"Pharmaceutical Technology","summary":"Astria Therapeutics licenses navenibart rights to Kaken for HAE - Pharmaceutical Technology","headline":"Astria Therapeutics licenses navenibart rights to Kaken for HAE","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-10","type":"pipeline","source":"simplywall.st","summary":"Aprea Therapeutics Insiders Still US$86k Away From Original Investment Value - simplywall.st","headline":"Aprea Therapeutics Insiders Still US$86k Away From Original Investment Value","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9uZUtheFYtR3dDc1p0SU5EYTBITHB3NGtjMUlubWJ1R0JNN2ZRSXNTT2FkZm5OQzUyby1zREZZNUEwOEo5VEZpTkpNX0hLVVpFM2xUOFVJSDVtTUlVZ041NUxRdF8ybWRQNkstVmpsUnlISVBnQkE?oc=5","date":"2025-04-22","type":"pipeline","source":"The Pharma Letter","summary":"Halda Therapeutics appointments CMO - The Pharma Letter","headline":"Halda Therapeutics appointments CMO","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":23895875,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-12599569,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":15933401,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}